Medtecs International Corporation Limited

TWSE:9103.TW

5.03 (TWD) • At close July 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q2
Revenue 28.89625.52726.10126.53824.63931.60458.85285.303237.718162.60935.82233.15535.34132.96329.59132.23530.04327.55333.39728.1925.64525.96123.00332.894052.4400045.187057.42
Cost of Revenue 25.12522.37724.40122.28136.43923.14146.14854.529117.475111.18730.59327.85330.06827.95225.16926.97925.71322.63127.85723.8622.10521.80418.8627.747041.95700035.102045.944
Gross Profit 3.7713.151.74.257-11.88.46312.70430.774120.24351.4225.2295.3025.2735.0114.4225.2564.334.9225.544.333.544.1574.1435.147010.48300010.085011.476
Gross Profit Ratio 0.1270.1230.0650.16-0.4790.2680.2160.3610.5060.3160.1460.160.1490.1520.1490.1630.1440.1790.1660.1540.1380.160.180.15600.20000.22300.2
Reseach & Development Expenses 00000000000000000000000000000000
General & Administrative Expenses 22.6816.64216.1927.11810.6067.1178.1115.5958.3934.7252.3272.5692.5862.3912.0432.4952.1642.2562.0032.2572.0932.4612.772.43305.6890005.62906.321
Selling & Marketing Expenses 3.2382.6673.5184.1195.9846.0257.6385.98316.9655.3511.3391.2611.6011.0821.5881.0851.5010.9491.7540.9121.1840.8861.2511.02401.6690001.61101.792
SG&A 25.9199.30919.7111.23716.5913.14215.88811.57825.37910.0763.6663.834.1873.4733.6313.583.6653.2053.7573.1693.2773.3474.0213.45707.3580007.2408.113
Other Expenses -4.125000000000000000000000000-0.1460001.66201.554
Operating Expenses 21.7949.30919.7110.314.63912.76414.12411.61627.5387.5873.0913.8453.6753.7373.473.8232.7973.4633.4773.1842.483.2513.4443.58907.2120008.90209.667
Operating Income -18.023-6.159-18.01-6.503-29.187-3.882-2.60618.61894.61741.5931.5741.4611.3261.2980.8441.6230.7561.6261.6971.2470.10.9730.1761.63603.2710001.18301.809
Operating Income Ratio -0.444-0.241-0.69-0.245-1.185-0.123-0.0440.2180.3980.2560.0440.0440.0380.0390.0290.050.0250.0590.0510.0440.0040.0370.0080.0500.0620000.02600.032
Total Other Income Expenses Net -0.6661.3261.2431.2322.061-0.4430.821-0.493-2.3951.522-0.534-0.984-0.365-1.073-0.605-0.9070.146-0.967-0.469-0.7830.522-0.527-0.13-0.7480-1.753000-1.35700.949
Income Before Tax -18.689-4.833-16.767-5.748-26.329-4.325-1.78518.70392.22242.8681.0290.4880.7210.4650.1860.7690.8110.751.3140.3780.7850.283-0.0080.88801.5850001.70902.758
Income Before Tax Ratio -0.432-0.189-0.642-0.217-1.069-0.137-0.030.2190.3880.2640.0290.0150.020.0140.0060.0240.0270.0270.0390.0130.0310.011-00.02700.030000.03800.048
Income Tax Expense 0.0130.1220.0480.0210.9660.4250.210.1980.6013.9750.2490.1020.1590.1130.1460.2280.2780.2641.0980.0630.6870.0260.2090.07400.2560000.32800.631
Net Income -18.147-3.879-15.708-5.358-24.897-3.699-1.72419.06692.82138.890.7770.3850.5610.3530.3410.5420.5340.4870.2150.3150.1280.255-0.2080.82101.3090001.40101.787
Net Income Ratio -0.405-0.152-0.602-0.202-1.01-0.117-0.0290.2240.390.2390.0220.0120.0160.0110.0120.0170.0180.0180.0060.0110.0050.01-0.0090.02500.0250000.03100.031
EPS -0.033-0.007-0.029-0.01-0.046-0.007-0.0030.0350.170.0710.0010.0010.0010.0010.0010.0010.0010.00100.00100.001-0.0010.00200.0030000.00300.004
EPS Diluted -0.033-0.007-0.029-0.01-0.046-0.007-0.0030.0350.170.0710.0010.0010.0010.0010.0010.0010.0010.00100.00100.001-0.0010.00200.0030000.00300.004
EBITDA -11.909-3.352-16.343-4.046-27.431-2.35-0.68520.37595.92244.2482.7932.5342.5062.5472.1393.0522.23.0992.7963.6922.4942.8452.1473.63707.6940006.21306.371
EBITDA Ratio -0.28-0.131-0.626-0.152-1.113-0.074-0.0120.2390.4040.2720.0780.0760.0710.0770.0720.0950.0730.1120.0840.1310.0970.110.0930.11100.1470000.13700.111